Hjem › Multipelt myelom › Delaware › Newark
Multipelt myelom kliniske forsøg i Newark, DE
4 studier for Multipelt myelom søger deltagere på steder i og omkring Newark (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruttererFase 3
- ChristianaCare Helen F Graham Cancer Center and Research Institute, Newark
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Medical Oncology Hematology Consultants /ID# 268560, Newark
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
RekruttererFase 3
- Christiana Care, Newark
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
RekruttererFase 2
- Medical Oncology Hematology Consultants, Newark
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Newark
- Ikke-småcellet lungecancer16 studier
- Prostatakræft10 studier
- Colorektal kræft9 studier
- Lungecancer9 studier
- Brystkræft8 studier
- Metastatisk cancer7 studier
- Kræft (alle typer)6 studier
- Bugspytkirtelkræft6 studier
- Ægstockræft5 studier
- Follikulært lymfom4 studier
- Kronisk lymfatisk leukæmi4 studier
- Mavekræft4 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.